Abbott’s Q1 earnings in focus as analysts see path to beat amid business strength

Abbott Laboratories (NYSE:ABT) is set to report its first-quarter earnings results on Wednesday, April 16th, before the market opens. Wall Street expects modest year-over-year growth, with analysts forecasting EPS of $1.07, representing a 9.2% increase, and revenue of $10.42 billion, up 4.2% from